Pat Cotroneo
Overview
Pat Cotroneo received an average of $3M in total compensation, including $449K in salary, at FibroGen from 2013 to 2021.
2021FibroGenChief Financial Officer
2020FibroGenChief Financial Officer
2019FibroGenChief Financial Officer
2018FibroGenChief Financial Officer
2017FibroGenChief Financial Officer
2016FibroGenChief Financial Officer
2015FibroGenChief Financial Officer
2014FibroGenChief Financial Officer
2013FibroGenChief Financial Officer
Source: SEC filings on April 28, 2022, April 13, 2021, April 23, 2020, April 23, 2019, April 24, 2018, April 24, 2017, and April 22, 2016.
Related executives
We found ten more executives who work or worked at FibroGen.
Enrique Conterno
FibroGen
Chief Executive Officer
Christine Chung
FibroGen
Senior Vice President, China Operations
Mark Eisner
FibroGen
Chief Medical Officer
Elias Kouchakji
FibroGen
Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance
Thane Wettig
FibroGen
Chief Commercial Officer
Juan Graham
FibroGen
Chief Financial Officer
K Yu
FibroGen
Chief Medical Officer
James Schoeneck
FibroGen